» Articles » PMID: 36312981

Identification of an Ergosterol Derivative with Anti-melanoma Effect from the Sponge-derived Fungus Sp. XWS03F09

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Oct 31
PMID 36312981
Authors
Affiliations
Soon will be listed here.
Abstract

It is difficult to treat malignant melanoma because of its high malignancy. New and effective therapies for treating malignant melanoma are urgently needed. Ergosterols are known for specific biological activities and have received widespread attention in cancer therapy. Here, , a kind of ergosterol from the secondary metabolites of the marine fungus sp., was extracted, isolated, purified, and further investigated the biological activities against melanoma. experiments, the anti-proliferation effect on tumor cells was detected by MTT and colony formation assay, and the anti-metastatic effect on tumor cells was investigated by wound healing assay and transwell assay. Subcutaneous xenograft models, histopathology, and immunohistochemistry have been used to verify the anti-tumor, toxic, and side effect . Besides, the anti-tumor mechanism of was studied by mRNA sequencing. , could inhibit the proliferation and migration of melanoma cells A375 and B16-F10 in a dose-dependent manner and promote tumor cell apoptosis through the mitochondrial apoptosis pathway. assays confirmed that could suppress melanoma growth by inducing cell apoptosis and reducing cell proliferation, and it did not have any notable toxic effects on normal tissues. may play an anti-melanoma role by upregulating gene expression. These findings suggest that may be a potential for the treatment of melanoma.

Citing Articles

Early Preclinical Studies of Ergosterol Peroxide and Biological Evaluation of Its Derivatives.

Ling T, Arroyo-Cruz L, Smither W, Seighman E, Martinez-Montemayor M, Rivas F ACS Omega. 2024; 9(35):37117-37127.

PMID: 39246459 PMC: 11375702. DOI: 10.1021/acsomega.4c04350.

References
1.
Maglangit F, Yu Y, Deng H . Bacterial pathogens: threat or treat (a review on bioactive natural products from bacterial pathogens). Nat Prod Rep. 2020; 38(4):782-821. DOI: 10.1039/d0np00061b. View

2.
Shriver M, Stroka K, Vitolo M, Martin S, Huso D, Konstantopoulos K . Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis. Oncogene. 2014; 34(32):4248-59. PMC: 4426246. DOI: 10.1038/onc.2014.358. View

3.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Sjoblom T, Jones S, Wood L, Parsons D, Lin J, Barber T . The consensus coding sequences of human breast and colorectal cancers. Science. 2006; 314(5797):268-74. DOI: 10.1126/science.1133427. View